Unfortunately, it’s a compounding problem that’s discouraging aspiring medical school students and pediatric residents from ...

(Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, and ...

Wednesday, several parents who know what that pain feels like were at the Indiana Statehouse to tell lawmakers about losing ...